GlassScriptPhysician profile
Kate Amanda Powers
NPI 1346834868
$2,296.53
in general payments reported to CMS, 2019-2025
20 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $619 · 2022: $499 · 2023: $619 · 2024: $295 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $541.92 | 2021-2025 | |
| Janssen Biotech, INC. | $511.67 | 2023-2025 | Tremfya |
| Allergan, INC. | $226.58 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $202.57 | 2022-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $145.33 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $131.42 | 2023 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $118.33 | 2021 | |
| Incyte Corporation | $82.53 | 2021 | |
| Genzyme Corporation | $53.32 | 2021-2025 | |
| Galderma Laboratories, L.P. | $47.76 | 2021-2025 | Nemluvio |
| Amgen INC. | $38.64 | 2021-2023 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.11 | 2021 | |
| Pfizer INC. | $28.76 | 2021 | |
| Vyne Pharmaceuticals INC. | $28.70 | 2021 | |
| Dermavant Sciences, INC. | $26.53 | 2023 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $18.85 | 2021 | |
| Almirall LLC | $16.72 | 2021 | |
| Leo Pharma INC. | $14.51 | 2021 | |
| Nabriva Therapeutics, Plc | $14.00 | 2021 | |
| Organon LLC | $12.28 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.